week of june 10: Greg Kunst - Aurion Biotech
Description
Top Stories
1. Microsoft CEO leaves Starbucks board
2. Seattle startup wins lawsuit against Boeing
3. VC backed biotech Vilya raises $71M
4. Lightrail SLU location debate
Opinion 1: The Stranger article
Opinion 2: PSBJ article
5. New record store on Vashon
About guest co-host Greg Kunst - Founder & CEO, Aurion Biotech:
Greg Kunst founded Aurion Biotech which is a company that develops cell therapies for the treatment of serious eye disorders. He is on the board of Pr3vent, Inc tackling vision health for babies. He's strategic advisor for Oculogica. Prior to this, he held leadership positions at Glockos Corporation and Alcon, both companies tackling eye health.
Host Rachel Horgan:
Rachel is an independent event producer, emcee and entrepreneur. She worked for the Business Journal for 5 years as their Director of Events interviewing business leaders on stage before launching the weekly podcast. She earned her communication degree from the University of San Diego.
Contact:
Email: info@theweeklyseattle.com
Instagram: @theweeklyseattle
United States
